ValiRx PLC - Approval of protocol amendment for VAL201 | Broadcast | BRR Media

Press enter to begin your search

ValiRx PLC - Approval of protocol amendment for VAL201

VAL

Thu, 20 Jun 2019, 12:20 BST

George Morris, COO, discusses the significant amendment to the VAL201 protocol and next steps for the clinical trial.

Dr George Morris

Chief Operating Officer

VAL

5d0b64d9221579216107e638

00:00

00:00

00:00

speed

0.5X

1.0X

1.5X

2.0X

SHOW MORE
FROM THIS COMPANY

ValiRx PLC - Approval of protocol amendment for VAL201

VAL Thu, 20 Jun 2019, 12:20 BST

ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.

Industry: Health Care

Contact: +44 (0)2476 796496
Barling Way
https://www.valirx.com/

George Morris, COO, discusses the significant amendment to the VAL201 protocol and next steps for the clinical trial.

Dr George Morris

Chief Operating Officer

POWERED BY